Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Delayed Quote USD

Shattuck Labs, Inc. (STTK)

Compare
0.9499
+0.0436
+(4.81%)
At close: April 11 at 4:00:01 PM EDT
0.9067
-0.04
(-4.55%)
After hours: April 11 at 7:19:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,721
5,721
1,657
652
30,017
Operating Expense
86,288
86,288
93,614
103,981
75,286
Operating Income
-80,567
-80,567
-91,957
-103,329
-45,269
Net Non Operating Interest Income Expense
5,174
5,174
4,669
1,592
625
Other Income Expense
-17
-17
-10
-208
-330
Pretax Income
-75,410
-75,410
-87,298
-101,945
-44,974
Net Income Common Stockholders
-75,410
-75,410
-87,298
-101,945
-44,974
Diluted NI Available to Com Stockholders
-75,410
-75,410
-87,298
-101,945
-44,974
Basic EPS
-1.49
--
-2.05
-2.41
-1.07
Diluted EPS
-1.49
--
-2.05
-2.41
-1.07
Basic Average Shares
50,758.2900
--
42,600.1900
42,378.8950
42,032.3840
Diluted Average Shares
50,758.2900
--
42,600.1900
42,378.8950
42,032.3840
Total Operating Income as Reported
-80,567
-80,567
-91,957
-103,329
-45,269
Total Expenses
86,288
86,288
93,614
103,981
75,286
Net Income from Continuing & Discontinued Operation
-75,410
-75,410
-87,298
-101,945
-44,974
Normalized Income
-75,410
-75,410
-87,298
-101,945
-44,974
Interest Income
5,174
5,174
4,669
1,592
625
Net Interest Income
5,174
5,174
4,669
1,592
625
EBIT
-80,567
-80,567
-91,957
-103,329
-45,269
EBITDA
-76,738
-76,738
-87,915
-100,256
-43,889
Reconciled Depreciation
3,829
3,829
4,042
3,073
1,380
Net Income from Continuing Operation Net Minority Interest
-75,410
-75,410
-87,298
-101,945
-44,974
Normalized EBITDA
-76,738
-76,738
-87,915
-100,256
-43,889
12/31/2021 - 10/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ARTV Artiva Biotherapeutics, Inc.
1.9800
+7.61%
 
LXEO Lexeo Therapeutics, Inc.
1.9800
-8.76%
 
ONCO Onconetix, Inc.
0.0623
+7.41%
 
ZVSA ZyVersa Therapeutics, Inc.
0.7700
-0.17%
 
ABVC ABVC BioPharma, Inc.
0.9140
-12.95%
 
BDRX Biodexa Pharmaceuticals Plc
1.7700
+12.74%
 
STRO Sutro Biopharma, Inc.
0.6024
+5.31%
 
CCCC C4 Therapeutics, Inc.
1.2400
+2.48%
 
DSGN Design Therapeutics, Inc.
2.8900
+3.58%
 
RLYB Rallybio Corporation
0.2503
-0.12%